The University of Chicago Header Logo

Connection

John Fung to Cyclosporine

Back to Details
This is a "connection" page, showing publications John Fung has written about Cyclosporine.
John Fung
Connection Strength
0.899
Cyclosporine
  1. Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation. Exp Clin Transplant. 2003 Jun; 1(1):48-55.
    View in: PubMed
    Score: 0.206
  2. FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation. 1994 Mar 27; 57(6):860-5.
    View in: PubMed
    Score: 0.109
  3. Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients. Transplant Proc. 1991 Dec; 23(6):3026-8.
    View in: PubMed
    Score: 0.093
  4. A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med. 2006 Jan 12; 354(2):141-50.
    View in: PubMed
    Score: 0.062
  5. Immunosuppressive therapy. Surg Clin North Am. 1999 Feb; 79(1):59-76.
    View in: PubMed
    Score: 0.038
  6. Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet. Am J Kidney Dis. 1998 Jun; 31(6 Suppl 1):S7-14.
    View in: PubMed
    Score: 0.036
  7. High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):1081-2.
    View in: PubMed
    Score: 0.033
  8. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation. 1992 May; 53(5):1056-62.
    View in: PubMed
    Score: 0.024
  9. Interaction between FK 506 and cyclosporine in dogs. Transplant Proc. 1991 Dec; 23(6):2797-9.
    View in: PubMed
    Score: 0.023
  10. Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect. Transplant Proc. 1991 Dec; 23(6):2957-8.
    View in: PubMed
    Score: 0.023
  11. FK 506 versus cyclosporine in pediatric liver transplantation. Transplant Proc. 1991 Dec; 23(6):3010-5.
    View in: PubMed
    Score: 0.023
  12. CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression. Transplant Proc. 1991 Dec; 23(6):3035-7.
    View in: PubMed
    Score: 0.023
  13. Renal function after conversion from cyclosporine to FK 506 in liver transplant patients. Transplant Proc. 1991 Dec; 23(6):3148-9.
    View in: PubMed
    Score: 0.023
  14. The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation. Transplant Proc. 1991 Dec; 23(6):3232-3.
    View in: PubMed
    Score: 0.023
  15. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg. 2005 Apr; 200(4):505-15; quiz A59-61.
    View in: PubMed
    Score: 0.015
  16. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant. 2003 Apr; 17(2):77-88.
    View in: PubMed
    Score: 0.013
  17. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. Am J Pathol. 2001 Apr; 158(4):1379-90.
    View in: PubMed
    Score: 0.011
  18. Tacrolimus for rescue of refractory renal allograft rejection. Transplant Proc. 1998 Jun; 30(4):1257-60.
    View in: PubMed
    Score: 0.009
  19. Central venulitis in the allograft liver: a clinicopathologic study. Transplantation. 1997 Jul 27; 64(2):252-7.
    View in: PubMed
    Score: 0.009
  20. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology. 1997 Jul-Aug; 44(16):1172-81.
    View in: PubMed
    Score: 0.009
  21. Five-year experience with tacrolimus rescue for renal allograft rejection. Transplant Proc. 1997 Feb-Mar; 29(1-2):306.
    View in: PubMed
    Score: 0.008
  22. Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era. Transplant Proc. 1997 Feb-Mar; 29(1-2):454-5.
    View in: PubMed
    Score: 0.008
  23. Tacrolimus rescue therapy for renal allograft rejection--five-year experience. Transplantation. 1997 Jan 27; 63(2):223-8.
    View in: PubMed
    Score: 0.008
  24. Weaning of immunosuppression in liver transplant recipients. Transplantation. 1997 Jan 27; 63(2):243-9.
    View in: PubMed
    Score: 0.008
  25. Tacrolimus rescue therapy for renal transplant rejection. Transplant Proc. 1996 Aug; 28(4):2119-20.
    View in: PubMed
    Score: 0.008
  26. Small bowel transplantation: current progress and clinical application. Hepatogastroenterology. 1996 Mar-Apr; 43(8):363-76.
    View in: PubMed
    Score: 0.008
  27. Randomised trialomania? The multicentre liver transplant trials of tacrolimus. Lancet. 1995 Nov 18; 346(8986):1346-50.
    View in: PubMed
    Score: 0.008
  28. Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg. 1994 Sep; 220(3):297-308; discussion 308-9.
    View in: PubMed
    Score: 0.007
  29. Two-year experience with FK 506 in pediatric patients. Transplant Proc. 1993 Feb; 25(1 Pt 1):619-21.
    View in: PubMed
    Score: 0.006
  30. Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. Transplant Proc. 1993 Feb; 25(1 Pt 1):781-3.
    View in: PubMed
    Score: 0.006
  31. Neurologic complications of FK 506. Transplant Proc. 1991 Dec; 23(6):3175-8.
    View in: PubMed
    Score: 0.006
  32. Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. Transplant Proc. 1991 Dec; 23(6):3269-71.
    View in: PubMed
    Score: 0.006
  33. FK 506 used as rescue therapy for human liver allograft recipients. Transplant Proc. 1991 Dec; 23(6):3005-6.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.